Literature DB >> 30500445

Meshes in a mess: Mesenchymal stem cell-based therapies for soft tissue reinforcement.

F Marinaro1, F M Sánchez-Margallo2, V Álvarez1, E López1, R Tarazona3, M V Brun4, R Blázquez5, J G Casado2.   

Abstract

Surgical meshes are frequently used for the treatment of abdominal hernias, pelvic organ prolapse, and stress urinary incontinence. Though these meshes are designed for tissue reinforcement, many complications have been reported. Both differentiated cell- and mesenchymal stem cell-based therapies have become attractive tools to improve their biocompatibility and tissue integration, minimizing adverse inflammatory reactions. However, current studies are highly heterogeneous, making it difficult to establish comparisons between cell types or cell coating methodologies. Moreover, only a few studies have been performed in clinically relevant animal models, leading to contradictory results. Finally, a thorough understanding of the biological mechanisms of mesenchymal stem cells in the context of foreign body reaction is lacking. This review aims to summarize in vitro and in vivo studies involving the use of differentiated and mesenchymal stem cells in combination with surgical meshes. According to preclinical and clinical studies and considering the therapeutic potential of mesenchymal stem cells, it is expected that these cells will become valuable tools in the treatment of pathologies requiring tissue reinforcement. STATEMENT OF SIGNIFICANCE: The implantation of surgical meshes is the standard procedure to reinforce tissue defects such as hernias. However, an adverse inflammatory response secondary to this implantation is frequently observed, leading to a strong discomfort and chronic pain in the patients. In many cases, an additional surgical intervention is needed to remove the mesh. Both differentiated cell- and stem cell-based therapies have become attractive tools to improve biocompatibility and tissue integration, minimizing adverse inflammatory reactions. However, current studies are incredibly heterogeneous and it is difficult to establish a comparison between cell types or cell coating methodologies. This review aims to summarize in vitro and in vivo studies where differentiated and stem cells have been combined with surgical meshes.
Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Foreign body reaction; Hernia; Mesenchymal stem cells; Surgical meshes

Mesh:

Year:  2018        PMID: 30500445     DOI: 10.1016/j.actbio.2018.11.042

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  4 in total

1.  Joint report on terminology for surgical procedures to treat pelvic organ prolapse.

Authors: 
Journal:  Int Urogynecol J       Date:  2020-03       Impact factor: 2.894

2.  Bioinspired Hydrogel Coating Based on Methacryloyl Gelatin Bioactivates Polypropylene Meshes for Abdominal Wall Repair.

Authors:  Andrada Serafim; Sergiu Cecoltan; Elena Olăreț; Diana-Maria Dragusin; Eugeniu Vasile; Valentin Popescu; Bogdan Stelian Manolescu Mastalier; Horia Iovu; Izabela-Cristina Stancu
Journal:  Polymers (Basel)       Date:  2020-07-28       Impact factor: 4.329

3.  Stromal vascular fraction cells as biologic coating of mesh for hernia repair.

Authors:  O Guillaume; B Pérez-Köhler; B Schädl; C Keibl; N Saxenhuber; P Heimel; E Priglinger; S Wolbank; H Redl; A Petter-Puchner; R Fortelny
Journal:  Hernia       Date:  2020-02-24       Impact factor: 4.739

4.  A Fibrin Coating Method of Polypropylene Meshes Enables the Adhesion of Menstrual Blood-Derived Mesenchymal Stromal Cells: A New Delivery Strategy for Stem Cell-Based Therapies.

Authors:  Federica Marinaro; Joana M Silva; Alexandre A Barros; Ivo M Aroso; Juan C Gómez-Blanco; Isaac Jardin; Jose J Lopez; María Pulido; María Ángeles de Pedro; Rui L Reis; Francisco Miguel Sánchez-Margallo; Javier G Casado; Esther López
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.